Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19

This longitudinal, prospective cohort study aimed to assess risk of QTc interval prolongation and its predicting factors in subjects treated with combinations containing hydroxychloroquine (HCQ) for COVID-19. Moderate-to-severe QTc prolongation during therapy was defined as a QTc interval >470 ms...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Antimicrob Agents
Autors principals: Padilla, Sergio, Telenti, Guillermo, Guillén, Lucía, García, José A., García-Abellán, Javier, Ding, Carolina, Mora, Antonia, García-Pachón, Eduardo, Gutiérrez, Félix, Masiá, Mar
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444635/
https://ncbi.nlm.nih.gov/pubmed/32853675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106142
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars